4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-038214
Chief Operating Officer sold 1,388 shares at an average $42.54 ($59,050)
- Chief Operating Officer acquired 2,834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bruno Julianne · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 1 in the form | +2,399 | 9,461 | D | ||
| 2025-03-11 | Sale : show line 2 in the form | −1,198 | $42.42 | $50,819 | 8,263 | D |
| 2025-03-11 | Exercise or conversion : show line 3 in the form | +435 | 8,698 | D | ||
| 2025-03-12 | Sale : show line 4 in the form | −190 | $43.32 | $8,231 | 8,508 | D |
| Open-market sales · 1,388 sh · avg $42.54 · $59,050 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −2,399 | 4,796 | D |
| 2025-03-11 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −435 | 0 | D |
Loading xslF345X05/ownership.xml…